| This article has been cited by |
| 1 | A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata | |
| Kerry-Ann L Dillon |
| Clinical, Cosmetic and Investigational Dermatology.2021;Volume 14()691 |
| [DOI] |
|
| 2 | Real-world experience and long-term evaluation of tofacitinib in refractory alopecia areata: A prospective, open-label, single-center study in Asian Arab population | |
| Husein Husein-ElAhmed,Nada Abdulla,Amina Al-Obaidli,Majid Ali-Alam,Martin Steinhoff |
| Dermatologic Therapy.2022;35(12)691 |
| [DOI] |
|
| 3 | Adverse events in patients treated with Jak-inhibitors for alopecia areata: A systematic review | |
| Andrea Sechi,Junhyuk Song,Massimo Dell'Antonia,Kristine Heidemeyer,Bianca Maria Piraccini,Michela Starace,Luigi Naldi |
| Journal of the European Academy of Dermatology and Venereology.2023;35(12)691 |
| [DOI] |
|
| 4 | Physiotherapeutic methods in the complex treatment of alopecia | |
| Vera Vasilievna Kiryanova,Yulia Sergeevna Egorova,Elena Vadimovna Petrova,Alla Askoldovna Potapchuk,Antonina Anatolievna Chaban |
| Fizioterapevt (Physiotherapist).2022;35(01)68 |
| [DOI] |
|
| 5 | JAK inhibition in the treatment of alopecia areata – a promising new dawn? | |
| Fathima Ferial Ismail,Rodney Sinclair |
| Expert Review of Clinical Pharmacology.2020;13(1)43 |
| [DOI] |
|
| 6 | Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers | |
| Emma Guttman-Yassky,Ana B. Pavel,Aisleen Diaz,Ning Zhang,Ester Del Duca,Yeriel Estrada,Brett King,Anindita Banerjee,Christopher Banfield,Lori Ann Cox,Martin E. Dowty,Karen Page,Michael S. Vincent,Weidong Zhang,Linda Zhu,Elena Peeva |
| Journal of Allergy and Clinical Immunology.2022;149(4)1318 |
| [DOI] |
|
| 7 | Off-label studies on tofacitinib in dermatology: a review | |
| Kyle Tegtmeyer,Jeffrey Zhao,Nolan J. Maloney,Giancarlo Atassi,Molly Beestrum,Peter A. Lio |
| Journal of Dermatological Treatment.2021;32(4)399 |
| [DOI] |
|
| 8 | The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients | |
| Mei-qi Mao,Yu-xin Ding,Jing Jing,Zhen-wei Tang,Yu-jie Miao,Xiao-shuang Yang,Yu-hong Chen,Sheng-zhao Chen,Xian-jie Wu,Zhong-fa Lu |
| Frontiers in Immunology.2023;14(4)399 |
| [DOI] |
|
| 9 | Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata | |
| Ana M. Montilla,Francisco Gómez-García,Pedro J. Gómez-Arias,Jesús Gay-Mimbrera,Jorge Hernández-Parada,Beatriz Isla-Tejera,Juan Ruano |
| Dermatology and Therapy.2019;9(4)655 |
| [DOI] |
|
| 10 | Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population | |
| Alanoud AlMarzoug,May AlOrainy,Lama AlTawil,Ghada AlHayaza,Rasha AlAnazi,Ahmed AlIssa,Afaf AlSheikh,Abdullah AlKhalifah,Ruaa AlHarithy |
| International Journal of Dermatology.2022;61(7)886 |
| [DOI] |
|
| 11 | RETRACTED: Crystal structure, anti-cervical cancer activity and docking studies of a new heterocycles compound | |
| Peng Li,Xin Ge,Hong-Li Wu |
| Main Group Chemistry.2019;18(2)63 |
| [DOI] |
|
| 12 | Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: A systematic review and meta-analysis | |
| Da-Ae Yu,Ye Eun Kim,Ohsang Kwon,Hyunsun Park |
| Indian Journal of Dermatology, Venereology and Leprology.2021;87(2)621 |
| [DOI] |
|
| 13 | Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis | |
| Farnam Barati Sedeh,Thorunn Elísabet Michaelsdóttir,Mattias Arvid Simon Henning,Gregor Borut Ernst Jemec,Kristina Sophie Ibler |
| Acta Dermato-Venereologica.2023;103(2)adv00855 |
| [DOI] |
|
| 14 | Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata | |
| Loren Krueger,Erik Peterson,Jerry Shapiro,Kristen Lo Sicco |
| JAAD Case Reports.2019;5(3)258 |
| [DOI] |
|
| 15 | The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review | |
| Ana B. Oliveira,Miguel Alpalhão,Paulo Filipe,João Maia-Silva |
| Dermatologic Therapy.2019;32(5)258 |
| [DOI] |
|
| 16 | Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review | |
| Malgorzata Papierzewska,Anna Waskiel-Burnat,Lidia Rudnicka |
| Clinical Drug Investigation.2023;43(5)325 |
| [DOI] |
|
| 17 | Homoeopathy In Management of Alopecia Areata – A Narrative Review | |
| Yogeshwari Gupta,Samridhi Sharma |
| Advancements in Homeopathic Research.2023;8(1)58 |
| [DOI] |
|
| 18 | Treatment of alopecia areata with individualised homoeopathic medicines: An evidence-based case series | |
| Bikash Biswas,Poulamy Singha Roy,Anupam Hazra |
| Journal of Integrated Standardized Homoeopathy.2022;5(1)67 |
| [DOI] |
|
| 19 | Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | |
| C. Garcia-Melendo,X. Cubiró,L. Puig |
| Actas Dermo-Sifiliográficas.2021;112(6)503 |
| [DOI] |
|
| 20 | Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | |
| C. Garcia-Melendo,X. Cubiró,L. Puig |
| Actas Dermo-Sifiliográficas (English Edition).2021;112(6)503 |
| [DOI] |
|
